
Sodium-coupled monocarboxylate transporters (SMCTs) are identified as novel D-serine transporters in the kidney, complementing the previously known D-serine transporter ASCT2. The differential expression and transport kinetics of these two systems explain the dynamics of D-serine as an emerging biomarker of kidney diseases.


coremsg

Transporter research primarily relies on the canonical substrates of well-established transporters. This approach has limitations when studying transporters for the low-abundant micromolecules, such as micronutrients, and may not reveal physiological functions of the transporters. While D-serine, a trace enantiomer of serine in the circulation, was discovered as an emerging biomarker of kidney function, its transport mechanisms in the periphery remain unknown. Here, using a multi-hierarchical approach from body fluids to molecules, combining multi-omics, cell-free synthetic biochemistry, and ex vivo transport analyses, we have identified two types of renal D-serine transport systems. We revealed that the small amino acid transporter ASCT2 serves as a D-serine transporter previously uncharacterized in the kidney and discovered D-serine as a noncanonical substrate of the sodium-coupled monocarboxylate transporters (SMCTs). These two systems are physiologically complementary, but ASCT2 dominates the role in the pathological condition. Our findings not only shed light on renal D-serine transport, but also clarify the importance of non-canonical substrate transport. This study provides a framework for investigating multiple transport systems of various trace micromolecules under physiological conditions and in multifactorial diseases.

### Competing Interest Statement

A patent (WO/2021/132691) has been applied by KAGAMI Inc., Nara Medical University, and NIBIOHN with P.W., S.M., P.K., T.K., M.Mit., and S.N. as inventors based on this research. M.Mit. is a founder and CEO of KAGAMI Inc., a startup company working on chiral amino acids analysis and research for medical applications. The authors declare no potential conflicts of interest.

A multi-hierarchical approach reveals D-serine as a hidden substrate of sodium-coupled monocarboxylate transporters

identification-of-sodium-coupled-monocarboxylate-transporters-as-novel-d-serine-transporters-in-the-kidney


Identification of Sodium-Coupled Monocarboxylate Transporters as Novel D-Serine Transporters in the Kidney
